Search

Filters

Clear Filters
5:25 PM - 5:30 PM ET

1101 - Concomitant Sub-ablative Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition in Recurrent and Metastatic Head and Neck Cancer
Speaker: Yazici, Gozde, MD - Hacettepe, Ankara, Ankara
5:30 PM - 5:35 PM ET

1102 - Development of a Machine Learning-Based 30-Day Survival Prediction Model for Patients Undergoing Palliative Radiation Therapy to Establish Optimal End-of-Life Care
Speaker: Lee, Tae Hoon, MD, PhD - Samsung Medical Center, Seoul, Seoul
5:05 PM - 5:10 PM ET

1103 - A Multifunctional BSA-THPC@Tc-99m Nanoplatform for Fluorescence/SPECT Dual-Mode Imaging-Guided Synergistic Sonodynamic and Radiotherapy of Tumors
Speaker: Chen, Liting - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an
5:10 PM - 5:15 PM ET

1104 - Impact of Proton Therapy Delivery Systems on Circulating Blood Dose
Speaker: Liu, Peilin, MD, PhD - Corewell Health William Beaumont University Hospital, Royal Oak, MI
5:15 PM - 5:20 PM ET

1105 - SFRT vs. CRT/SBRT: A Clinical Trials Simulated (CTS) Study on Short-Term Objective Response Rate, Long-Term Local Control Rate and Efficacy Gain Prediction for Bulky Tumors
Speaker: Bi, Suyan, PhD - Yuebei People's Hospital, Shaoguan, Guangdong
5:20 PM - 5:25 PM ET

1106 - Toward a Common Biological Dose Scale for SBRT and SIRT Using Imaging-Derived Liver Functional Toxicity Response
Speaker: Wei, Lise, PhD, MS - University of Michigan, Ann Arbor, MI
5:25 PM - 5:30 PM ET

1107 - Monte Carlo-Validated In Vivo Optical Dosimetry and Source Tracking for HDR Brachytherapy
Speaker: Willy, Kevin, BS - Dartmouth College, Hanover, NH
5:30 PM - 5:35 PM ET

1108 - Multi-Outcome Machine Learning Models Demonstrate Radiation Therapy Quality Assurance Metrics as Consistent Predictors of Clinical Endpoints for Head and Neck Cancer in RTOG 0522
Speaker: Wang, Du, PhD, MS - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
12:35 PM - 12:40 PM ET

1109 - Pre-Treatment Diagnostic and Staging Efficiency in Patients with Non-Small Cell Lung Cancer (NSCLC): A Systems Operations Audit in an Integrated Health System
Speaker: Mohindra, Pranshu, MD, MMM, FABS - University Hospitals Seidman Cancer Center, Cleveland, OH, Cleveland, OH
3:10 PM - 3:20 PM ET

111 - HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA) with Protons or Photons vs. Standard of Care for Head and Neck Squamous Cell Carcinoma: A Randomized Trial
Speaker: Elbers, Jos, MD, PhD - Erasmus Medical Center, Rotterdam, Zuid-Holla
9:15 AM - 9:18 AM ET

111 - HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA) with Protons or Photons vs. Standard of Care for Head and Neck Squamous Cell Carcinoma: A Randomized Trial
Speaker: Elbers, Jos, MD, PhD - Erasmus Medical Center, Rotterdam, Zuid-Holla
12:40 PM - 12:45 PM ET

1110 - Assessing Insurer Market Share Association with Insurance Denials, Appeals, and Prolonged Prior Authorization for Patients Undergoing Proton Beam Therapy
Speaker: Randolph, Allison, MD, MBA - Johns Hopkins Medicine, Baltimore, MD